" "Baird Reiterates "$40.00" Price Target for Continental Resources, Inc. (CLR)


Piper Jaffray Companies restated a "buy" rating and issued a $41.00 price objective on shares of Continental Resources in a research report on Friday, October 6th. It has underperformed by 12.65% the S&P500. See Continental Resources, Inc. Therefore 38% are positive. Continental Resources has a 52 week low of $29.08 and a 52 week high of $60.30. The stock's average target of $59.75 is 61.53% above today's ($36.99) share price. The firm earned "Neutral" rating on Friday, November 6 by TH Capital. The rating was maintained by FBR Capital on Monday, May 1 with "Mkt Perform". The rating was initiated by JP Morgan on Wednesday, December 9 with "Overweight". The company was maintained on Tuesday, September 5 by KeyBanc Capital Markets. As per Thursday, August 25, the company rating was maintained by Nomura. The firm has "Buy" rating by H.C. Wainwright given on Wednesday, August 30. Wells Fargo initiated the stock with "Outperform" rating in Tuesday, August 16 report. (NASDAQ:IRWD) has "Buy" rating given on Wednesday, August 2 by Mizuho.

Some buy side analysts are also providing their Analysis on Continental Resources, Inc., where 11 analysts have rated the stock as Strong buy, 11 analysts have given a Buy signal, 8 said it's a HOLD, 1 reported it as Underperform and 0 analysts rated the stock as Sell. The average stock price target is $46.15 with 9 brokers rating the stock a strong buy, 13 brokers rating the stock a buy, 11 brokers rating the stock a hold, 0 brokers rating the stock a underperform, and finally 1 broker rating the stock a sell. Benjamin F Edwards And invested in 0.01% or 3,300 shares. The hedge fund held 832,000 shares of the energy company at the end of 2017Q2, valued at $26.90 million, down from 1.30M at the end of the previous reported quarter. First Foundation owns 3,448 shares. Focusing in on the past five trading days, shares have changed 0.45%. Retail Bank Of Ny Mellon Corp has invested 0% in Ironwood Pharmaceuticals, Inc. Comerica Commercial Bank has 0% invested in Continental Resources, Inc. Los Angeles & Equity Rech stated it has 0.2% of its portfolio in Davita Inc (NYSE:DVA). Bnp Paribas Asset Management Holdings holds 0.02% or 65,529 shares. Advisory Serv Ntwk Ltd Liability owns 700 shares or 0% of their USA portfolio. Illinois-based Alyeska Inv Grp Limited Partnership has invested 0.37% in Davita Inc (NYSE:DVA). Blackrock Inc, a New York-based fund reported 27,704 shares. Fmr Limited Com reported 13.21 million shares stake. (NYSE:CLR). Goldman Sachs Gp holds 676,846 shares or 0.01% of its portfolio.

DaVita Inc., formerly DaVita HealthCare Partners Inc., operates two divisions: DaVita Kidney Care and DaVita Medical Group (DMG). The company's market capitalization is $14.88 billion. The Kidney Care division consists of its the United States dialysis and related lab services, its ancillary services and strategic initiatives, including its global operations, and its corporate administrative support. (Nicholas Financial). It has a 20.71 P/E ratio. The Company's DMG division is a patient- and physician-focused integrated healthcare delivery and management firm that provides medical services to members through capitation contracts. (NYSE:CLR). 142 are held by Plante Moran Limited Com. Therefore 100% are positive. CLR was included in 107 notes of analysts from July 21, 2015. The rating was maintained by RBC Capital Markets on Thursday, November 19 with "Outperform". RBC Capital Markets maintained Davita Inc (NYSE:DVA) rating on Tuesday, February 16. The rating was downgraded by Capital One to "Equal-Weight" on Wednesday, April 27. Analysts rating the company a 3 indicate a Hold recommendation. Finally, Parametric Portfolio Associates LLC lifted its holdings in Continental Resources by 6.5% in the first quarter. $59,445 worth of Davita Inc (NYSE:DVA) was sold by HILGER JAMES K. BERG CHARLES sold $553,607 worth of stock. (NYSE:CLR). 21,597 were accumulated by Rafferty Asset Ltd Liability. $85,670 worth of Davita Inc (NYSE:DVA) was sold by Rodriguez Javier on Monday, May 15. Its down 0.03, from 0.95 in 2017Q1. It improved, as 47 investors sold CLR shares while 95 reduced holdings. 5 funds opened positions while 2 raised stakes. Whittier Trust Communications Of Nevada stated it has 23,078 shares. (NYSE:CLR). Franklin Res reported 8,000 shares or 0% of all its holdings. Hodges holds 34,600 shares or 0.07% of its portfolio. Citigroup initiated Continental Resources, Inc. (NYSE:CLR). Parallax Volatility Advisers LP holds 101,090 shares. While it's Return on Investment (ROI) value is -0.7%. (NYSE:CLR) for 1,531 shares. Jefferies Group Limited Liability Company has invested 0% in Continental Resources, Inc. Alliancebernstein Ltd Partnership has 0.01% invested in Continental Resources, Inc.

Evaluating Insider Trading And Ownership For AcelRx Pharmaceuticals, Inc. (ACRX)
TRADEMARK VIOLATION NOTICE: This story was originally reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. Finally, LMR Partners LLP purchased a new stake in shares of AcelRx Pharmaceuticals during the 2nd quarter valued at $319,000.

In case of Revenue Estimates, 21 analysts have provided their consensus Average Revenue Estimates for Continental Resources, Inc.as 708.66 Million. Jefferies Group analyst M. Hsu forecasts that the oil and natural gas company will post earnings of $1.68 per share for the year. The company reported the estimated EPS by analysts was $-0.01/share. CLR's profit will be $3.86 million for 926.75 P/E if the $0.01 EPS becomes a reality.

Since May 12, 2017, it had 2 buys, and 0 selling transactions for $3.72 million activity. The insider Hamm Harold bought 51,765 shares worth $2.19 million.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.